Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective To determine whether liquid chromatography–tandem mass spectrometry (LC-MS/MS) determination of total (TT) and free (FT) testosterone is more specific than extraction chromatography–radioimmunoassay (RIA) for distinguishing women with polycystic ovary syndrome (PCOS) from controls, and whether differing cut-off values should be used depending on the setting. Design Prospective case-control cohort study. Setting Tertiary care center and reference laboratory. Interventions Blood sampling. Participants 100 PCOS patients and 100 controls. Main Outcome Measure Circulating TT measured by RIA and LC-MS/MS, and FT measured by equilibrium dialysis using the RIA or LC-MS/MS-generated TT values. Results Testosterone measurement by RIA and LC-MS/MS differentiated PCOS from controls similarly; detection of PCOS was higher for FT for both methods. TT values demonstrated greater overlap between PCOS and controls than did FT for both RIA (80% vs. 42% overlap) and LC-MS/MS (52% vs. 67% overlap). A lower cut-off value was better suited for the study of patients seen in the clinical (referred) setting (35 ng/dL and 4.0 ng/dL for TT and FT, respectively) than in the screening of a general population (50 ng/dL and 5.0 ng/dL for TT and FT, respectively). Conclusions Extraction chromatography and RIA and LC-MS/MS measurements of testosterone have similar performance for differentiating PCOS from healthy controls; LC-MS/MS may be preferable given its relative ease of automation. Compared to FT, measurement of TT has relatively limited value for distinguishing PCOS from normal. Finally, different cut-off values should be considered depending on the clinical/investigative setting, with higher values used in the study of biased (e.g. clinical or referred) populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 5×
“Note: In our calculations we considered two different clinical situations: [1] the evaluation of womenwith suspected androgen excess in a referral clinic, where a 70%prevalence of PCOS can be expected; and [2] the evaluation of unselected women from a broader population, as in epidemiological studies, where a 10% prev…”
BackgroundMethodSelf-citationMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · cited 1×
“However, many factors favor the use of LC-MS/MS for TT measurement over that of extraction chromatography–RIA, including [1] the lack of standardization of RIAs, [2] the decreasing availability of extraction chromatography–RIA in reference laboratories, [3] the reliance of RIAs on radioisotopes, [4] significant batch…”
BackgroundSelf-citationAndrogen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Self-citationWang, C., Catlin, D. H., Demers, L. M., Starcevic, B., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031287 · Cited by 580
Handelsman, D. J., & Wartofsky, L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3375 · Cited by 368
Serum Testosterone Assays—Accuracy Matters
Matsumoto, A. M., & Bremner, W. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032175 · Cited by 217 · cited 1×
“However, many factors favor the use of LC-MS/MS for TT measurement over that of extraction chromatography–RIA, including [1] the lack of standardization of RIAs, [2] the decreasing availability of extraction chromatography–RIA in reference laboratories, [3] the reliance of RIAs on radioisotopes, [4] significant batch…”
BackgroundImmunoassays for Testosterone in Women: Better than a Guess?
Herold, D. A., & Fitzgerald, R. L. (2003) · Clinical Chemistry · doi:10.1373/49.8.1250 · Cited by 203
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Ezeh, U., Yildiz, B. O., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1295 · Cited by 193
Self-citation
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Self-citationAdolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Metadata
- Authors
- Salameh, W. A., Redor-Goldman, M. M., Clarke, N. J., Mathur, R., Azziz, R., & Reitz, R. E.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 101
- Issue
- 4
- Pages
- 1135-1141.e2
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2124090884
- Cited by
- 67
- References
- 9
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. https://app.cochat.ai/papers/10.1016/j.fertnstert.2013.12.056
- The paper
- Salameh, W. A., Redor-Goldman, M. M., Clarke, N. J., Mathur, R., Azziz, R., & Reitz, R. E. (2014). Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2013.12.056
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.